---
title: 'Standard-of-care systemic therapy with or without SBRT in patients with oligoprogressive
  breast cancer or NSCLC (CURB oligoprogression): an open-label, randomised, controlled,
  phase 2 study'
date: '2024-08-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39120748/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240809181323&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...